INNOVATIVE MEDTECH, INC. Quarterly Debt-to-equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Innovative Medtech, Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2024.
  • Innovative Medtech, Inc. Debt-to-equity for the quarter ending September 30, 2024 was -181 %, a 34.2% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 -181 +93.8 +34.2% Sep 30, 2024
Q2 2024 -243 +17 +6.53% Jun 30, 2024
Q1 2024 -412 -150 -57.5% Mar 31, 2024
Q4 2023 -308 +41.3 +11.8% Dec 31, 2023
Q3 2023 -275 +240 +46.7% Sep 30, 2023
Q2 2023 -260 +637 +71% Jun 30, 2023
Q1 2023 -261 +1.65K +86.3% Mar 31, 2023
Q4 2022 -349 Dec 31, 2022
Q3 2022 -515 Sep 30, 2022
Q2 2022 -897 Jun 30, 2022
Q1 2022 -1.91K Mar 31, 2022
Q3 2014 -100 -0.01 -0.01% Oct 31, 2014
Q2 2014 -100 0 0% Jul 31, 2014
Q1 2014 -100 Apr 30, 2014
Q4 2013 -100 Jan 31, 2014
Q3 2013 -100 Oct 31, 2013
Q2 2013 -100 Jul 31, 2013
Q1 2012 -105 Apr 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.